Miami HCA Affiliate, Mercy Hospital, Installs a Mazor Robotics Renaissance® Guidance System for Spine Surgery
May 04 2016 - 04:30AM
Business Wire
- Represents First Purchase Order for
Renaissance to Date in the 2016 Second Quarter
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a developer of
innovative guidance systems and complementary products, recently
installed a Renaissance Guidance System at Mercy Hospital in Miami.
Mercy Hospital is the sixth HCA-affiliated facility to purchase a
Renaissance system and the second hospital in Miami-Dade County to
receive a system in the last six months.
“HCA is one of the nation’s leading providers of healthcare
services and we are proud to enhance our involvement with them,”
said Mazor Robotics CEO Ori Hadomi. “This system placement is
consistent with our U.S. strategy to focus on prominent hospitals
in large metropolitan markets, such as Miami.” See how Renaissance
works.
Mercy Hospital is a 488-bed acute care facility and has been
serving the healthcare needs of South Florida for 60 years. Mercy
Hospital is accredited by Joint Commission and offers a full range
of services to the residents of Miami-Dade County and surrounding
communities.
This represents the first purchase order for the Renaissance
system to date in the second quarter ending June 30, 2016. The
Company will announce the total number of system orders for the
second quarter in early July.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing
through innovation by developing and introducing revolutionary
robotic-based technology and products aimed at redefining the gold
standard of quality care. Mazor Robotics Renaissance® Guidance
System enables surgeons to conduct spine and brain procedures in a
more accurate and secure manner. For more information, please visit
www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other securities laws. Any statements in this release about
future expectations, plans or prospects for the Company, including
without limitation, statements regarding the Company’s strategy to
focus on prominent hospitals in large metropolitan markets, and
other statements containing the words “believes,” “anticipates,”
“plans,” “expects,” “will” and similar expressions are
forward-looking statements. These statements are only predictions
based on Mazor's current expectations and projections about future
events. There are important factors that could cause Mazor's actual
results, level of activity, performance or achievements to differ
materially from the results, level of activity, performance or
achievements expressed or implied by the forward-looking
statements. Those factors include, but are not limited to, the
impact of general economic conditions, competitive products,
product demand and market acceptance risks, reliance on key
strategic alliances, fluctuations in operating results, and other
factors indicated in Mazor's filings with the Securities and
Exchange Commission (SEC) including those discussed under the
heading "Risk Factors" in Mazor’s annual report on Form 20-F filed
with the SEC on May 2, 2016 and in subsequent filings with the SEC.
For more details, refer to Mazor's SEC filings. Mazor undertakes no
obligation to update forward-looking statements to reflect
subsequent occurring events or circumstances, or to changes in our
expectations, except as may be required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160504005588/en/
U.S. Contacts: EVC GroupInvestorsMichael Polyviou,
212-850-6020mpolyviou@evcgroup.comDoug Sherk,
415-652-9100dsherk@evcgroup.comorMediaDavid Schemelia,
646-201-5431dave@evcgroup.com
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Feb 2024 to Mar 2024
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Mar 2023 to Mar 2024